Potrero Medical, Inc. filed a Form D with the Securities and Exchange Commission on 2025-09-02.
Potrero Medical, Inc. filed a Form D notice of an exempt securities offering with the SEC on September 2, 2025. The filing reports $2.28M sold. Its industry group is Biotechnology. It names Christopher Dewey (Director), Rich Keenan (Chief Product Officer), Mark Goldwasser (Director) (SEC Form D, September 2, 2025).
Is this your company?
Sell to companies like Potrero Medical, Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
New Form D on file · 2025-09-02 · the record
Pitching, partnering or investing alongside them? See who really runs and owns Potrero Medical, Inc.
Free to see. No signup.
More on the people and the money behind Potrero Medical, Inc., from the filings we hold.
Ceros Financial Services, Inc. received sales compensation on this raise and on 10 other raises we hold, nearest in date first:
Biotechnology raises by companies based in California, filed in September 2025, largest first.
Get an email when Potrero Medical, Inc. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
We'll show it in your MentionFox inbox when Potrero Medical, Inc. raises, hires or launches. No email unless you switch it on.
Watch Potrero Medical, Inc. →Get the full cited report on Potrero Medical, Inc.
What the filing shows about Potrero Medical, Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
A Full Report on Potrero Medical, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
The filing gives Potrero Medical, Inc.'s address as 26142 Eden Landing Road, Hayward, CA 94545.
Saved here on this device in the meantime, so nothing is lost either way.
Full funding history for Potrero Medical, Inc. →
This is the company's own disclosure. A payment disclosed on a Form D is a disclosed use of proceeds, not a finding of wrongdoing.
Potrero Medical, Inc. is a registered filer with the SEC (CIK 1609048) and has filed since 2023-04-10. 4 filings are on record, the latest on 2026-05-29.
A filing shows the company exists and what it reports about itself. It is not an audit or a rating.
Potrero Medical, Inc.'s Form D of 2025-09-02 names Christopher Dewey, Rich Keenan, Mark Goldwasser and 4 more as its officers, directors or promoters.
Its new offerings report $29.73M sold across 4 offerings, as its own filings state.
Each marker is one filing. The larger marker is the filing this page is about.
Trailing twelve months. 766 filings in Biotechnology, totalled by week.
Christopher Dewey is named as Director on the Form D that Potrero Medical, Inc. filed with the SEC on 2 September 2025, one of 7 people that filing names.
On the filing as: Executive Officer.
Rich Keenan is named as Chief Product Officer on the Form D that Potrero Medical, Inc. filed with the SEC on 2 September 2025, one of 7 people that filing names.
Mark Goldwasser is named as Director on the Form D that Potrero Medical, Inc. filed with the SEC on 2 September 2025, one of 7 people that filing names.
Maurice Ferre is named as Director on the Form D that Potrero Medical, Inc. filed with the SEC on 2 September 2025, one of 7 people that filing names.
Ramachandra Reddy is named as Director on the Form D that Potrero Medical, Inc. filed with the SEC on 2 September 2025, one of 7 people that filing names.
On the filing as: Executive Officer, Director.
Todd Dunn is named as Chief Executive Officer on the Form D that Potrero Medical, Inc. filed with the SEC on 2 September 2025, one of 7 people that filing names.
Chad Zaring is named as Director on the Form D that Potrero Medical, Inc. filed with the SEC on 2 September 2025, one of 7 people that filing names.
7 people named on the filing — 2 holding an executive role and 5 as directors only.
Named as of the 2025-09-02 filing. Titles and locations are exactly as the filing states — not independently confirmed elsewhere.
No investor is drawn from a Form D — the form states how many invested and never who.
What the filing shows about Potrero Medical, Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
A Full Report on Potrero Medical, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Potrero Medical, Inc. covers
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
You land back on this company when you are in.
Not ready to upgrade? Keep this one in view instead.
Watchlist Potrero Medical, Inc.You get an alert in MentionFox the next time this company shows up.
If you're behind Potrero Medical, Inc.: the weeks after a raise are watched the same way — by other investors sizing you up, and by founders checking who just got funded. FoxPlug turns your commits, deploys, and releases into that story automatically. GetFoxChat puts a guide on your own site so the people this filing just sent you don't leave after one page.
Sourced from the filing index on sec.gov.
Each opens in a new tab, filled in for Potrero Medical, Inc.. With no account yet, you sign up free and land on the result.
On these lists: Biotech raises in San Francisco Bay Area
Share your raise. This card is drawn from the company's own Form D filing, and sharing needs no account.
https://mentionfox.com/funding/potrero-medical-inc-form-d-25000001